Marina Lugova, executive VP Business Development at API manufacturer Synbias Pharma, discusses why Switzerland was chosen as the company's headquarters, Synbias's internationalization strategy, and why it is the partner of choice.
We have chosen Switzerland for several reasons: a stable political and economic environment, the fact many Big Pharma companies have offices there, the strong network of professional consulting services in Switzerland, its excellent infrastructure and finally, its talent pool
